Proteolytic activation transforms heparin cofactor II into a host defense molecule

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6303-6310

  Kalle, Martina ^a   Papareddy, Praveen ^a   Kasetty, Gopinath ^a   Tollefsen, Douglas M ^b   Malmsten, Martin ^c   Mor̈gelin, Matthias ^a   Schmidtchen, Artur ^a  

^a LUND UNIVERSITY   (Sweden)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN COFACTOR II; LEUKOCYTE ELASTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM ISOLATE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFECTION SENSITIVITY; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PSEUDOMONAS INFECTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; HEPARIN COFACTOR II; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEOLYSIS;

EID: 84879072604     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203030     Document Type: Article

References (38)

1. Huntington, J. A. 2006. Shape-shifting serpins - advantages of a mobile mechanism. Trends Biochem. Sci. 31: 427-435. (Pubitemid 44131659)
2. Rau, J. C., L. M. Beaulieu, J. A. Huntington, and F. C. Church. 2007. Serpins in thrombosis, hemostasis and fibrinolysis. J. Thromb. Haemost. 5(Suppl 1): 102-115. (Pubitemid 46958823)
3. He, L., C. P. Vicente, R. J. Westrick, D. T. Eitzman, and D. M. Tollefsen. 2002. Heparin cofactor II inhibits arterial thrombosis after endothelial injury. J. Clin. Invest. 109: 213-219. (Pubitemid 34083741)
4. Villa, P., J. Aznar, A. Vaya, F. España, F. Ferrando, Y. Mira, and A. Estellés. 1999. Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis. Thromb. Haemost. 82: 1011-1014. (Pubitemid 29419710)
5. Tollefsen, D. M. 2010. Vascular dermatan sulfate and heparin cofactor II. Prog Mol Biol Transl Sci 93: 351-372.
6. Baglin, T. P., R. W. Carrell, F. C. Church, C. T. Esmon, and J. A. Huntington. 2002. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc. Natl. Acad. Sci. USA 99: 11079-11084. (Pubitemid 34920882)
7. Hoffman, M., C. W. Pratt, R. L. Brown, and F. C. Church. 1989. Heparin cofactor II-proteinase reaction products exhibit neutrophil chemoattractant activity. Blood 73: 1682-1685. (Pubitemid 19131918)
8. Noda, A., H. Wada, F. Kusiya, M. Sakakura, K. Onishi, K. Nakatani, E. C. Gabazza, N. Asahara, M. Tsukada, T. Nobori, and H. Shiku. 2002. Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation. Clin. Appl. Thromb. Hemost. 8: 265-271.
9. Kario, K., T. Matsuo, K. Kodama, S. Katayama, and H. Kobayashi. 1992. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia. Thromb. Res. 66: 435-444.
10. Rossi, E. B., C. L. Duboscq, and L. C. Kordich. 1999. [Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role]. Medicina (B. Aires) 59: 95-104.
11. Tollefsen, D. M., and C. A. Pestka. 1985. Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure. Blood 66: 769-774. (Pubitemid 15242456)
12. Papareddy, P., V. Rydengård, M. Pasupuleti, B. Walse, M. Mörgelin, A. Chalupka, M. Malmsten, and A. Schmidtchen. 2010. Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog. 6: e1000857.
13. Papareddy, P., M. Kalle, G. Kasetty, M. Mörgelin, V. Rydengård, B. Albiger, K. Lundqvist, M. Malmsten, and A. Schmidtchen. 2010. C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules. J. Biol. Chem. 285: 28387-28398.
14. Nordahl, E. A., V. Rydengård, M. Mörgelin, and A. Schmidtchen. 2005. Domain 5 of high molecular weight kininogen is antibacterial. J. Biol. Chem. 280: 34832-34839. (Pubitemid 41504617)
15. Frick, I. M., P. Akesson, H. Herwald, M. Mörgelin, M. Malmsten, D. K. Nägler, and L. Björck. 2006. The contact system - a novel branch of innate immunity generating antibacterial peptides. EMBO J. 25: 5569-5578. (Pubitemid 44847197)
16. Loof, T. G., O. Schmidt, H. Herwald, and U. Theopold. 2011. Coagulation systems of invertebrates and vertebrates and their roles in innate immunity: the same side of two coins? J. Innate Immun. 3: 34-40.
17. Esmon, C. T., J. Xu, and F. Lupu. 2011. Innate immunity and coagulation. J. Thromb. Haemost. 9(Suppl 1): 182-188.
18. Lundqvist, K., H. Herwald, A. Sonesson, and A. Schmidtchen. 2004. Heparin binding protein is increased in chronic leg ulcer fluid and released from granulocytes by secreted products of Pseudomonas aeruginosa. Thromb. Haemost. 92: 281-287. (Pubitemid 39172308)
19. Lehrer, R. I., M. Rosenman, S. S. Harwig, R. Jackson, and P. Eisenhauer. 1991. Ultrasensitive assays for endogenous antimicrobial polypeptides. J. Immunol. Methods 137: 167-173.
20. Pratt, C. W., R. B. Tobin, and F. C. Church. 1990. Interaction of heparin cofactor II with neutrophil elastase and cathepsin G. J. Biol. Chem. 265: 6092-6097.
21. Maekawa, H., H. Sato, and D. M. Tollefsen. 2000. Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex. Thromb. Res. 100: 443-451. (Pubitemid 32056978)
22. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415: 389-395. (Pubitemid 34100944)
23. Schmidtchen, A. 2000. Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers. Acta Derm. Venereol. 80: 179-184.
24. Pemberton, P. A., P. E. Stein, M. B. Pepys, J. M. Potter, and R. W. Carrell. 1988. Hormone binding globulins undergo serpin conformational change in inflammation. Nature 336: 257-258. (Pubitemid 18264407)
25. Kim, H. S., J. H. Krege, K. D. Kluckman, J. R. Hagaman, J. B. Hodgin, C. F. Best, J. C. Jennette, T. M. Coffman, N. Maeda, and O. Smithies. 1995. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. USA 92: 2735-2739.
26. Bodenstine, T. M., R. E. Seftor, Z. Khalkhali-Ellis, E. A. Seftor, P. A. Pemberton, and M. J. Hendrix. 2012. Maspin: molecular mechanisms and therapeutic implications. Cancer Metastasis Rev. 31: 529-551.
27. Dawson, D. W., O. V. Volpert, P. Gillis, S. E. Crawford, H. Xu, W. Benedict, and N. P. Bouck. 1999. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285: 245-248. (Pubitemid 29329995)
28. Davis, A. E., III, F. Lu, and P. Mejia. 2010. C1 inhibitor, a multi-functional serine protease inhibitor. Thromb. Haemost. 104: 886-893.
29. Malmström, E., M. Mörgelin, M. Malmsten, L. Johansson, A. Norrby-Teglund, O. Shannon, A. Schmidtchen, J. C. Meijers, and H. Herwald. 2009. Protein C inhibitor - a novel antimicrobial agent. PLoS Pathog. 5: e1000698.
30. Pratt, C. W., H. C. Whinna, and F. C. Church. 1992. A comparison of three heparin-binding serine proteinase inhibitors. J. Biol. Chem. 267: 8795-8801.
31. Sørensen, O. E., P. Follin, A. H. Johnsen, J. Calafat, G. S. Tjabringa, P. S. Hiemstra, and N. Borregaard. 2001. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97: 3951-3959.
32. Simanski, M., B. Köten, J. M. Schröder, R. Gläser, and J. Harder. 2012. Antimicrobial RNases in cutaneous defense. J. Innate Immun. 4: 241-247.
33. Boix, E., M. Torrent, D. Sánchez, and M. V. Nogués. 2008. The antipathogen activities of eosinophil cationic protein. Curr. Pharm. Biotechnol. 9: 141-152. (Pubitemid 352024690)
34. García-Montoya, I. A., T. S. Cendón, S. Arévalo-Gallegos, and Q. Rascón-Cruz. 2012. Lactoferrin a multiple bioactive protein: an overview. Biochim. Biophys. Acta 1820: 226-236.
35. Rydengård, V., O. Shannon, K. Lundqvist, L. Kacprzyk, A. Chalupka, A. K. Olsson, M. Mörgelin, W. Jahnen-Dechent, M. Malmsten, and A. Schmidtchen. 2008. Histidine-rich glycoprotein protects from systemic Candida infection. PLoS Pathog. 4: e1000116.
36. Choi, K. Y., L. N. Chow, and N. Mookherjee. 2012. Cationic host defence peptides: multifaceted role in immune modulation and inflammation. J. Innate Immun. 4: 361-370.
37. Maekawa, H., and D. M. Tollefsen. 1996. Role of the proposed serpin-enzyme complex receptor recognition site in binding and internalization of thrombin-heparin cofactor II complexes by hepatocytes. J. Biol. Chem. 271: 18604-18609. (Pubitemid 26322723)
38. Perlmutter, D. H., G. I. Glover, M. Rivetna, C. S. Schasteen, and R. J. Fallon. 1990. Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes. Proc. Natl. Acad. Sci. USA 87: 3753-3757. and Kock Foundations Läkarutbildning och Forskning)